![LOGO](https://capedge.com/proxy/8-K/0001193125-20-033395/g836032g0211140549442.jpg)
Financial Results
Quarter Ended December 31, 2019
Net loss attributable to common stockholders was $50.1 million, or $0.22 per diluted share, for the quarter ended December 31, 2019, compared to net income attributable to common stockholders of $5.3 million, or $0.02 per diluted share, for the quarter ended December 31, 2018. Net loss attributable to common stockholders for the quarter ended December 31, 2019 includes (i) a $37.9 million, or $0.17 per diluted share, real estate impairment loss, (ii) a $10.8 million, or $0.05 per diluted share, loss on early extinguishment of debt and (iii) a $7.4 million, or $0.03 per diluted share, expense from thenon-cashwrite-off of deferred financing costs. The loss on early extinguishment of debt and thewrite-off of deferred financing costs were incurred in connection with the $1.25 billion refinancing of 1633 Broadway in November 2019.
Funds from Operations (“FFO”) attributable to common stockholders was $40.0 million, or $0.18 per diluted share, for the quarter ended December 31, 2019, compared to $56.3 million, or $0.24 per diluted share, for the quarter ended December 31, 2018. FFO attributable to common stockholders for the quarters ended December 31, 2019 and 2018 includes the impact ofnon-core items, which are listed in the table on page 11. The aggregate of these items, net of amounts attributable to noncontrolling interests, decreased FFO attributable to common stockholders for the quarter ended December 31, 2019 and 2018 by $18.3 million and $3.0 million, respectively, or $0.08 and $0.01 per diluted share, respectively.
Core FFO attributable to common stockholders, which excludes the impact of thenon-core items listed on page 11, was $58.3 million, or $0.26 per diluted share, for the quarter ended December 31, 2019, compared to $59.3 million, or $0.25 per diluted share, for the quarter ended December 31, 2018.
Year Ended December 31, 2019
Net loss attributable to common stockholders was $36.9 million, or $0.16 per diluted share, for the year ended December 31, 2019, compared to net income attributable to common stockholders of $9.1 million, or $0.04 per diluted share, for the year ended December 31, 2018. Net loss attributable to common stockholders for the year ended December 31, 2019 includes (i) a $37.9 million, or $0.16 per diluted share, real estate impairment loss, (ii) a $10.8 million, or $0.05 per diluted share, loss on early extinguishment of debt, (iii) a $7.4 million, or $0.03 per diluted share, expense from thenon-cashwrite-off of deferred financing costs and (iv) a $1.0 million, or $0.00 per diluted share, gain on sale of real estate (Liberty Place). The loss on early extinguishment of debt and thewrite-off of deferred financing costs were incurred in connection with the $1.25 billion refinancing of 1633 Broadway in November 2019. Net income attributable to common stockholders for the year ended December 31, 2018, included (i) $32.2 million, or $0.13 per diluted share, of gain on sale of real estate, net of “sting” taxes and (ii) a $41.6 million, or $0.17 per diluted share, real estate impairment loss.
FFO attributable to common stockholders was $208.2 million, or $0.90 per diluted share, for the year ended December 31, 2019, compared to $224.5 million, or $0.94 per diluted share, for the year ended December 31, 2018. FFO attributable to common stockholders for the years ended December 31, 2019 and 2018 includes the impact ofnon-core items, which are listed in the table on page 11. The aggregate of these items, net of amounts attributable to noncontrolling interests, decreased FFO attributable to common stockholders for the years ended December 31, 2019 and 2018 by $19.0 million and $5.4 million, respectively, or $0.08 and $0.02 per diluted share, respectively.
Core FFO attributable to common stockholders, which excludes the impact of thenon-core items listed on page 11, was $227.2 million, or $0.98 per diluted share, for the year ended December 31, 2019, compared to $229.9 million, or $0.96 per diluted share, for the year ended December 31, 2018.
3